Why sponsors should be using community research in obesity and diabetes trials
The World Health Organization has called obesity “one of today’s most blatantly visible – yet most neglected – public health…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…
-
Project Optimus: The evolution of dose optimisation in oncology
In 2021, the Project Optimus initiative was launched by the US Food and Drug Administration’s (FDA) Oncology Center of Excellence,…
-
Beyond compliance: The strategic role of PASS in rare disease therapy success
By taking a more strategic approach to PASS, you can secure long-term market access, gain regulatory trust, and provide critical…
-
Realising the opportunities for growth in the European orphan drug market
The European orphan drug market is growing and is already comparable in size and scope to the US market. The…
-
Orphan drugs: How to avoid costly stock losses in Europe
Estimates suggest that there could be around 300 million people worldwide living with a rare disease. A disease is classed as…
-
Oncology and eClinical solutions: How one company is adapting to the challenges
Meticulous planning is central to building an effective clinical trial, powered by well-designed Interactive Response Technology (IRT) which provides not…
-
The next stage of DCTs: New survey sheds light on how to move forward with mobile visits
Mobile research models are making a positive difference in clinical research, helping drug sponsors bring studies to patient populations that…
-
Enhancing patient engagement and outcomes in the NHS
Medication non-adherence is an enduring issue in the UK healthcare system, costing the NHS a staggering £930 million annually.[i] Despite…
-
Why mobile nurse visits have a place in clinical trials, according to industry survey
Clinical trials are on the move, with an increasing number of sponsors exploring ways to bring their studies closer to…
